Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

PURPOSE: Results from 2 patient-reported outcome studies of allergic conjunctivitis sufferers who used olopatadine 0.2% and azelastine 0.05% are analyzed. METHODS: The PACE (Pataday Allergic Conjunctivitis Evaluation) multi-center, prospective, open-label study examined patient perceptions of olopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Epstein, Arthur B, Van Hoven, Peter T, Kaufman, Alan, Carr, Warner W
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709004/
https://www.ncbi.nlm.nih.gov/pubmed/19668586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709004/
https://www.ncbi.nlm.nih.gov/pubmed/19668586

Ejemplares similares